Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
XOLREMDI is an oral prescription medicine for people aged 12 and older with WHIM syndrome, designed to increase the number of certain white blood cells (neutrophils and lymphocytes) in the bloodstream. It targets the underlying cause of WHIM syndrome to help improve immune function.
Parse Score